239 related articles for article (PubMed ID: 30196110)
1. Effective suppression of donor specific antibody production by Cathepsin S inhibitors in a mouse transplantation model.
Kubo K; Kawato Y; Nakamura K; Nakajima Y; Nakagawa TY; Hanaoka K; Oshima S; Fukahori H; Inami M; Morokata T; Higashi Y
Eur J Pharmacol; 2018 Nov; 838():145-152. PubMed ID: 30196110
[TBL] [Abstract][Full Text] [Related]
2. mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+ Antibody-Suppressing T cells.
Avila CL; Zimmerer JM; Elzein SM; Pham TA; Abdel-Rasoul M; Bumgardner GL
Transplantation; 2016 Sep; 100(9):1898-906. PubMed ID: 27362313
[TBL] [Abstract][Full Text] [Related]
3. Calcineurin Inhibitor Minimization With Ixazomib, an Investigational Proteasome Inhibitor, for the Prevention of Antibody Mediated Rejection in a Preclinical Model.
Reese SR; Wilson NA; Huang G; Redfield RR; Zhong W; Djamali A
Transplantation; 2015 Sep; 99(9):1785-95. PubMed ID: 25919767
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive protocol with delayed use of low-dose tacrolimus after aortic transplantation suppresses donor-specific anti-MHC class I and class II antibody production in rats.
Matia I; Fellmer P; Splith K; Varga M; Adamec M; Kämmerer I; Feldbrügge L; Krenzien F; Hau HM; Atanasov G; Schmelzle M; Jonas S
Ann Transplant; 2014 May; 19():225-32. PubMed ID: 24815872
[TBL] [Abstract][Full Text] [Related]
5. Tracing Donor-MHC Class II Reactive B cells in Mouse Cardiac Transplantation: Delayed CTLA4-Ig Treatment Prevents Memory Alloreactive B-Cell Generation.
Yang J; Chen J; Young JS; Wang Q; Yin D; Sciammas R; Chong AS
Transplantation; 2016 Aug; 100(8):1683-91. PubMed ID: 27362308
[TBL] [Abstract][Full Text] [Related]
6. The PI3Kδ selective inhibitor AS2541019 suppresses donor-specific antibody production in rat cardiac and non-human primate renal allotransplant models.
Marui T; Fukahori H; Ito M; Kaneko Y; Maeda M; Tsujimoto S; Morokata T
Int Immunopharmacol; 2019 Oct; 75():105756. PubMed ID: 31344556
[TBL] [Abstract][Full Text] [Related]
7. Bortezomib for refractory acute antibody-mediated rejection in kidney transplant recipients: A single-centre case series.
De Sousa-Amorim E; Revuelta I; Diekmann F; Cofan F; Lozano M; Cid J; Palou E; Sole M; Campistol JM; Oppenheimer F
Nephrology (Carlton); 2016 Aug; 21(8):700-4. PubMed ID: 26492594
[TBL] [Abstract][Full Text] [Related]
8. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
[TBL] [Abstract][Full Text] [Related]
9. Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
Haas M; Mirocha J; Reinsmoen NL; Vo AA; Choi J; Kahwaji JM; Peng A; Villicana R; Jordan SC
Kidney Int; 2017 Mar; 91(3):729-737. PubMed ID: 28104301
[TBL] [Abstract][Full Text] [Related]
10. Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization.
Vo AA; Sinha A; Haas M; Choi J; Mirocha J; Kahwaji J; Peng A; Villicana R; Jordan SC
Transplantation; 2015 Jul; 99(7):1423-30. PubMed ID: 25606792
[TBL] [Abstract][Full Text] [Related]
11. Differential modulation of donor-specific antibodies after B-cell depleting therapies to cure chronic antibody mediated rejection.
Touzot M; Couvrat-Desvergnes G; Castagnet S; Cesbron A; Renaudin K; Cantarovich D; Giral M
Transplantation; 2015 Jan; 99(1):63-8. PubMed ID: 25029384
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cathepsin S reduces allogeneic T cell priming but not graft-versus-host disease against minor histocompatibility antigens.
Fujii H; Ivison SM; Shimizu H; Kajiwara R; Kariminia A; Yan M; Dutz JP; Schultz KR
Biol Blood Marrow Transplant; 2012 Apr; 18(4):546-56. PubMed ID: 22178962
[TBL] [Abstract][Full Text] [Related]
13. Disruption of Tfh:B Cell Interactions Prevents Antibody-Mediated Rejection in a Kidney Transplant Model in Rats: Impact of Calcineurin Inhibitor Dose.
Steines L; Poth H; Schuster A; Amann K; Banas B; Bergler T
Front Immunol; 2021; 12():657894. PubMed ID: 34135891
[TBL] [Abstract][Full Text] [Related]
14. The mosaic of immunosuppressive drugs.
Masri MA
Mol Immunol; 2003 Jul; 39(17-18):1073-7. PubMed ID: 12835079
[TBL] [Abstract][Full Text] [Related]
15. B cells as antigen-presenting cells in transplantation rejection and tolerance.
Chong AS
Cell Immunol; 2020 Mar; 349():104061. PubMed ID: 32059816
[TBL] [Abstract][Full Text] [Related]
16. Blockade of IL-6/IL-6R Signaling Attenuates Acute Antibody-Mediated Rejection in a Mouse Cardiac Transplantation Model.
Ma M; Sun Q; Li X; Deng G; Zhang Y; Yang Z; Han F; Huang Z; Fang Y; Liao T; Sun Q
Front Immunol; 2021; 12():778359. PubMed ID: 34777394
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive effects of DTCM-G, a novel inhibitor of the mTOR downstream signaling pathway.
Shibasaki S; Yamashita K; Goto R; Wakayama K; Tsunetoshi Y; Zaitsu M; Igarashi R; Haga S; Ozaki M; Umezawa K; Todo S
Transplantation; 2013 Feb; 95(4):542-50. PubMed ID: 23269193
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
[TBL] [Abstract][Full Text] [Related]
19. Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial.
Eskandary F; Dürr M; Budde K; Doberer K; Reindl-Schwaighofer R; Waiser J; Wahrmann M; Regele H; Spittler A; Lachmann N; Firbas C; Mühlbacher J; Bond G; Halloran PF; Chong E; Jilma B; Böhmig GA
Trials; 2019 Jan; 20(1):37. PubMed ID: 30635033
[TBL] [Abstract][Full Text] [Related]
20. SAHA, an HDAC inhibitor, attenuates antibody-mediated allograft rejection.
Zhang X; Guo M; Kang Y; Liu F; Zheng X; Han S; Fu S; Hong S; Ding G; Wang L; Wang QX
Transplantation; 2013 Sep; 96(6):529-37. PubMed ID: 23912176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
